Patents by Inventor Pei-Ying LIAO

Pei-Ying LIAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10894023
    Abstract: Disclosed herein is an oral dosage formulation suitable for treating a neurodegenerative disorder. The oral dosage formulation contains both sustained-release and immediate-release drugs. The sustained-release drug in the oral dosage formulation is memantine, and the immediate-release drug in the oral dosage formulation is donepezil and/or memantine, and the formulation is characterized in having a pH-independent dissolution profile of memantine at a pH range from about 1.0 to about 7.0.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: January 19, 2021
    Assignee: CENTER LABORATORIES, INC.
    Inventors: Meng-Ju Lee, Shu-Hsien Chang, Chih-Chiang Yang, Yuan-Chih Le, Tse-Ching Lin, Ko-Chiang Chen, Lai-Cheng Chin, Tai-Yin Ke, Pei-Ying Liao
  • Publication number: 20190388340
    Abstract: Disclosed herein is an oral dosage formulation suitable for treating a neurodegenerative disorder. The oral dosage formulation contains both sustained-release and immediate-release drugs. The sustained-release drug in the oral dosage formulation is memantine, and the immediate-release drug in the oral dosage formulation is donepezil and/or memantine, and the formulation is characterized in having a pH-independent dissolution profile of memantine at a pH range from about 1.0 to about 7.0.
    Type: Application
    Filed: June 20, 2019
    Publication date: December 26, 2019
    Applicants: Center Laboratories, Inc., Medical and Pharmaceutical Industry Technology and Development Center
    Inventors: Meng-Ju LEE, Shu-Hsien CHANG, Chih-Chiang YANG, Yuan-Chih LE, Tse-Ching LIN, Ko-Chiang CHEN, Lai-Cheng CHIN, Tai-Yin KE, Pei-Ying LIAO